-DOCSTART- -X- O
Six -X- _ O
volunteers -X- _ O
experienced -X- _ O
severe -X- _ O
inflammatory -X- _ O
response -X- _ O
during -X- _ O
the -X- _ O
Phase -X- _ O
I -X- _ O
clinical -X- _ O
trial -X- _ O
of -X- _ O
a -X- _ O
monoclonal -X- _ O
antibody -X- _ O
that -X- _ O
was -X- _ O
designed -X- _ O
to -X- _ O
stimulate -X- _ O
a -X- _ O
regulatory -X- _ O
T -X- _ O
cell -X- _ O
response. -X- _ O
Soon -X- _ O
after -X- _ O
the -X- _ O
trial -X- _ O
began -X- _ O
, -X- _ O
each -X- _ O
volunteer -X- _ O
experienced -X- _ O
a -X- _ O
“cytokine -X- _ B-Patient
storm” -X- _ I-Patient
, -X- _ O
a -X- _ O
dramatic -X- _ O
increase -X- _ O
in -X- _ O
cytokine -X- _ O
concentrations. -X- _ O
The -X- _ O
monoclonal -X- _ O
antibody -X- _ O
, -X- _ O
TGN1412 -X- _ O
, -X- _ O
raised -X- _ O
serum -X- _ O
concentrations -X- _ O
of -X- _ O
both -X- _ O
pro- -X- _ O
and -X- _ O
anti-inflammatory -X- _ O
cytokines -X- _ O
το -X- _ O
very -X- _ O
hiγh -X- _ O
values -X- _ O
during -X- _ O
the -X- _ O
first -X- _ O
day -X- _ O
, -X- _ O
while -X- _ O
lymphocyte -X- _ O
and -X- _ O
monocyte -X- _ O
concentrations -X- _ O
plummeted. -X- _ O
Because -X- _ O
the -X- _ O
subjects -X- _ O
were -X- _ O
healthy -X- _ O
and -X- _ O
had -X- _ O
no -X- _ O
prior -X- _ O
indications -X- _ O
of -X- _ O
immune -X- _ O
deficiency -X- _ O
, -X- _ O
this -X- _ O
event -X- _ O
provided -X- _ O
an -X- _ O
unusual -X- _ O
opportunity -X- _ O
to -X- _ O
study -X- _ O
the -X- _ O
dynamic -X- _ B-Outcome
interactions -X- _ I-Outcome
of -X- _ O
cytokines -X- _ B-Patient
and -X- _ O
other -X- _ O
measured -X- _ O
parameters. -X- _ O
Here -X- _ O
, -X- _ O
the -X- _ O
response -X- _ O
histories -X- _ O
of -X- _ O
nine -X- _ B-Patient
cytokines -X- _ I-Patient
have -X- _ O
been -X- _ O
modeled -X- _ O
by -X- _ O
a -X- _ O
set -X- _ O
of -X- _ O
linear -X- _ O
ordinary -X- _ O
differential -X- _ O
equations. -X- _ O
A -X- _ O
general -X- _ O
search -X- _ O
procedure -X- _ O
identifies -X- _ O
parameters -X- _ O
of -X- _ O
the -X- _ O
model -X- _ O
, -X- _ O
whose -X- _ O
response -X- _ O
fits -X- _ O
the -X- _ O
data -X- _ O
well -X- _ O
during -X- _ O
the -X- _ O
five-day -X- _ O
measurement -X- _ O
period. -X- _ O
The -X- _ O
eighteenth-order -X- _ O
model -X- _ O
reveals -X- _ O
plausible -X- _ O
cause-and-effect -X- _ O
relationships -X- _ O
among -X- _ O
the -X- _ O
cytokines -X- _ O
, -X- _ O
showing -X- _ O
how -X- _ O
each -X- _ O
cytokine -X- _ O
induces -X- _ O
or -X- _ O
inhibits -X- _ O
other -X- _ O
cytokines. -X- _ O
It -X- _ O
suggests -X- _ O
that -X- _ O
perturbations -X- _ B-Outcome
in -X- _ I-Outcome
IL2 -X- _ I-Outcome
, -X- _ I-Outcome
IL8 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
IL10 -X- _ I-Outcome
have -X- _ I-Outcome
the -X- _ I-Outcome
most -X- _ I-Outcome
significant -X- _ I-Outcome
inductive -X- _ I-Outcome
effect -X- _ I-Outcome
, -X- _ I-Outcome
while -X- _ I-Outcome
IFN-γ -X- _ I-Outcome
and -X- _ I-Outcome
IL12 -X- _ I-Outcome
have -X- _ I-Outcome
the -X- _ I-Outcome
greatest -X- _ I-Outcome
inhibiting -X- _ I-Outcome
effect -X- _ I-Outcome
on -X- _ I-Outcome
other -X- _ I-Outcome
cytokine -X- _ I-Outcome
concentrations. -X- _ I-Outcome
Although -X- _ I-Outcome
TNF-α -X- _ I-Outcome
is -X- _ I-Outcome
a -X- _ I-Outcome
major -X- _ I-Outcome
pro-inflammatory -X- _ I-Outcome
factor -X- _ I-Outcome
, -X- _ I-Outcome
IFN-γ -X- _ I-Outcome
and -X- _ I-Outcome
three -X- _ I-Outcome
other -X- _ I-Outcome
cytokines -X- _ I-Outcome
have -X- _ I-Outcome
faster -X- _ I-Outcome
initial -X- _ I-Outcome
and -X- _ I-Outcome
median -X- _ I-Outcome
response -X- _ I-Outcome
to -X- _ I-Outcome
TGN1412 -X- _ I-Outcome
infusion. -X- _ I-Outcome
Principal-component -X- _ I-Outcome
analysis -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
data -X- _ I-Outcome
reveals -X- _ I-Outcome
three -X- _ I-Outcome
clusters -X- _ I-Outcome
of -X- _ I-Outcome
similar -X- _ I-Outcome
cytokine -X- _ I-Outcome
responses -X- _ I-Outcome
: -X- _ I-Outcome
[ -X- _ I-Outcome
TNF-α -X- _ I-Outcome
, -X- _ I-Outcome
IL1 -X- _ I-Outcome
, -X- _ I-Outcome
IL10 -X- _ I-Outcome
] -X- _ I-Outcome
, -X- _ I-Outcome
[ -X- _ I-Outcome
IFN-γ -X- _ I-Outcome
, -X- _ I-Outcome
IL2 -X- _ I-Outcome
, -X- _ I-Outcome
IL4 -X- _ I-Outcome
, -X- _ I-Outcome
IL8 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
IL12 -X- _ I-Outcome
] -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
[ -X- _ I-Outcome
IL6 -X- _ I-Outcome
] -X- _ I-Outcome
. -X- _ I-Outcome
IL1 -X- _ I-Outcome
, -X- _ I-Outcome
IL6 -X- _ I-Outcome
, -X- _ I-Outcome
IL10 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
TNF-α -X- _ I-Outcome
have -X- _ I-Outcome
the -X- _ I-Outcome
highest -X- _ I-Outcome
degree -X- _ I-Outcome
of -X- _ I-Outcome
variability -X- _ I-Outcome
in -X- _ I-Outcome
response -X- _ I-Outcome
to -X- _ I-Outcome
uncertain -X- _ I-Outcome
initial -X- _ I-Outcome
conditions -X- _ I-Outcome
, -X- _ I-Outcome
exogenous -X- _ I-Outcome
effects -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
parameter -X- _ I-Outcome
estimates. -X- _ I-Outcome
This -X- _ O
study -X- _ O
illuminates -X- _ O
details -X- _ O
of -X- _ O
a -X- _ O
cytokine -X- _ O
storm -X- _ O
event -X- _ O
, -X- _ O
and -X- _ O
it -X- _ O
demonstrates -X- _ O
the -X- _ O
value -X- _ O
of -X- _ O
linear -X- _ O
modeling -X- _ O
for -X- _ O
interpreting -X- _ O
complex -X- _ O
, -X- _ O
coupled -X- _ O
biological -X- _ O
system -X- _ O
dynamics -X- _ O
from -X- _ O
empirical -X- _ O
data -X- _ O
. -X- _ O

